Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
21.15
-0.33 (-1.54%)
Jan 22, 2025, 12:00 PM EST - Market open
Progyny Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Progyny stock have an average target of 19.17, with a low estimate of 17 and a high estimate of 24. The average target predicts a decrease of -9.36% from the current stock price of 21.15.
Analyst Consensus: Buy
* Price targets were last updated on Dec 2, 2024.
Analyst Ratings
The average analyst rating for Progyny stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 2 | 2 | 2 | 1 | 1 |
| Hold | 4 | 5 | 5 | 5 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy → Hold Downgrades $22 → $17 | Buy → Hold | Downgrades | $22 → $17 | -19.62% | Dec 2, 2024 |
| Barclays | Barclays | Buy Maintains $30 → $17 | Buy | Maintains | $30 → $17 | -19.62% | Nov 14, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $22 → $21 | Strong Buy | Maintains | $22 → $21 | -0.71% | Nov 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $18 → $17 | Hold | Maintains | $18 → $17 | -19.62% | Nov 13, 2024 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $26 → $19 | Strong Buy → Hold | Downgrades | $26 → $19 | -10.17% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
1.17B
from 1.09B
Increased by 7.20%
Revenue Next Year
1.18B
from 1.17B
Increased by 1.11%
EPS This Year
0.56
from 0.62
Decreased by -9.78%
EPS Next Year
0.62
from 0.56
Increased by 10.47%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.2B | 1.3B | 1.4B | |||
| Avg | 1.2B | 1.2B | 1.3B | |||
| Low | 1.1B | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 10.7% | 7.1% | 22.7% | |||
| Avg | 7.2% | 1.1% | 11.5% | |||
| Low | 2.6% | -6.5% | -1.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 0.67 | 1.02 | 1.32 | |||
| Avg | 0.56 | 0.62 | 0.91 | |||
| Low | 0.49 | 0.45 | 0.60 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 8.4% | 82.1% | 114.1% | |||
| Avg | -9.8% | 10.5% | 47.1% | |||
| Low | -21.0% | -19.4% | -2.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.